Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Desmodesmus pannonicus water extract may help reduce skin pigmentation, heal wounds, and promote hair growth.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

The study suggests a possible increase in androgen receptors in patients with frontal fibrosing alopecia, but more research is needed.

Racial minorities faced more Covid-19 blame due to anti-fatness and structural racism.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Use finasteride over dutasteride for hair loss; consider topical treatments and weigh risks.

Recent advances in hair loss treatments show significant progress.

Hair loss treatments show limited improvement, sunscreen thickness affects vitamin D production, and the effectiveness of IVIg for toxic epidermal necrolysis is uncertain.

Africa's low COVID-19 rates may be linked to early measures and possibly higher estrogen levels in women.

UK dermatologists commonly use corticosteroids and minoxidil to treat hair loss conditions.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

"HairSentinel" accurately detects hairfall trends using simple user data, helping identify health risks early.

Higher variability in systolic blood pressure increases long-term mortality risk in coronary artery disease patients.

Women experience more side effects and have worse blood pressure control from hypertension treatments than men, despite using different medications.

New treatments are needed for non-scarring alopecia due to current limitations.

Cyperus rotundus oil effectively reduces unwanted hair without side effects.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

Finasteride effectively treats BPH but requires continuous use to maintain benefits.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.